HCV screening practices and prevalence in an MCO, 2000-2007

American Journal of Managed Care

Volumn 17, Issue 8, 2011, Pages 548-555

  Roblin, Douglas W ^a   Smith, Bryce D ^b   Weinbaum, Cindy M ^b   Sabin, Miriam E ^b  

^a KAISER PERMANENTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; GENDER; HEPATITIS C; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; RISK FACTOR; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MANAGED CARE PROGRAMS; MASS SCREENING; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 80052090970     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: Institute of Medicine; 2010.
2. Di Bisceglie AM, Lyra AC, Schwartz M, et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol. 2003;98(9):2060-2063. (Pubitemid 37185806)
3. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485-1491.
4. O'Connor S, Ward JW. Hepatocellular carcinoma - United States, 2001-2006. MMWR. 2010;59(17):517-520.
5. Rein DB, Wittenborn JS, Weinbaum CMW, Sabin M, Smith BDL, Sarah B. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis. In press.
6. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714. (Pubitemid 46780630)
7. Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005;41(1):88-96. (Pubitemid 40066386)
8. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998;47(No. RR-19).
9. Shatin D, Schech SD, Patel K, McHutchison JG. Population-based hepatitis C surveillance and treatment in a national managed care organization. Am J Manag Care. 2004;10(4):250-256. (Pubitemid 38480794)
10. Leverence RR, Williams RL, Pace W, et al. Context of clinical care: the case of hepatitis C in underserved communities - a report from the Primary Care Multiethnic Network (PRIME Net) Consortium. J Am Board Fam Med. 2009;22(6):638-646.
11. Shehab TM, Sonnad SS, Lok AS. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat. 2001;8(5):377-383. (Pubitemid 34205892)
12. Shehab TM, Sonnad S, Gebremariam A, Schoenfeld P. Knowledge of hepatitis C screening and management by internal medicine residents: trends over 2 years. Am J Gastroenterol. 2002;97(5):1216-1222. (Pubitemid 34478125)
13. Zickmund, SL, Brown KE, Bielefeldt K. A systematic review of provider knowledge of hepatitis C: is it enough for a complex disease? Dig Dis Sci. 2007;52(10):2550-2556. (Pubitemid 47373918)
14. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996;334(26):1691-1696. (Pubitemid 26193620)
15. Sanka P, Jones NL. To tell or not to tell: primary care patients' disclosure deliberations. Arch Intern Med. 2005;165(20):2378-2383. (Pubitemid 41640850)
16. Brady KA, Weiner M, Turner BJ. Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals. J Infect. 2009;59(1):62-69.
17. Hagan H, Campbell J, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006;121(6):710-719. (Pubitemid 46280261)
18. Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction. 2002;97(10):1289-1294.
19. Volk ML, Tocco R, Saini S, Lok AS. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009;50(6):1750-1755.
20. Singh GK, Miller BA, Hankey BF, Feuer EJ, Pickle LW. Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part I: all cancers among men. J Natl Cancer Inst. 2002;94(12):904-915. (Pubitemid 34778089)
21. Singh GK, Miller BA, Hankey BF. Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part II: lung and colorectal cancers. J Natl Cancer Inst. 2002;94(12):916-925. (Pubitemid 34778090)
22. Saitz R, Mulvey KP, Plough A, Samet JH. Physician unawareness of serious substance abuse. Am J Drug Alcohol Abuse. 1997;23(3):343-354. (Pubitemid 27332577)
23. Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-7):1-23.
24. Mast EE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006;55(RR-16):1-33.